GE Healthcare is extending its Discovery product line with the introduction of the new Discovery PET/CT 600.

This system delivers the next evolution in PET/CT technologies, bringing powerful options to physicians to discover ways to detect disease early and manage with confidence. This new platform offers the scintillator with the high sensitivity, the next generation of MotionFree technology to capture detail and precision in areas subject to motion, plus enhanced workflow and fast reconstruction with the IBM BladeCenter.

This new addition to GE’s Discovery family of scanners continues GE’s commitment to help enable the earlier detection and monitoring of disease with advanced molecular imaging technology, in both hardware and software.

The new system will be optimized for use in oncology, which represents more than 90 percent of clinical PET/CT exams. The system continues using high-sensitivity crystals in the industry, along with GE’s exclusive VUE Point HD, High Definition imaging to help clinicians advance towards the goal of Motion Free PET/CT imaging. It reportedly has wide-view imaging for PET and CT and according to the manufacturer, has two to four times faster reconstruction.

Discovery Dimension's high-definition PET image processing for patient motion management and clinical productivity provide features that together address motion, which is one of the most significant factors in lesion characterization that degrade today’s PET/CT image quality. These technologies are continuously developed through the work of GE research and global clinical research partners in pursuit of motion free PET/CT imaging. The newest version of Discovery Dimension helps clinicians advance towards the goal of motion free PET/CT imaging by allowing the clinician to address imaging mismatches related to respiratory and cardiac motion. These include motion correction techniques that effectively improve clinical results and minimize blur caused by motion.

GE Healthcare is aslo showing a new application for PET image generation. This technology, called VUE Point, can help improve small lesion detectability, clinical confidence and exam productivity. Available on the Discovery Dimension with new installations or by ContinuumTM field upgrades for installed base Discovery ST systems, clinicians can perform advanced PET image generation to improve both qualitative and quantitative accuracy.

VUE Point incorporates advanced proprietary image reconstruction algorithms; including volume scatter correction and a patented image projection technique developed at GE’s Global Research facility, and is enabled by the Volume CT reconstruction technology development. VUE Point is applicable to both 2D and 3D PET acquisition modes, static, dynamic and motion imaging.


Related Content

News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
Subscribe Now